Daiwa Securities Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.22M | Buy |
40,360
+7,940
| +24% | +$437K | 0.01% | 602 |
|
|
2025
Q1 | $2.29M | Buy |
32,420
+9,805
| +43% | +$693K | 0.01% | 564 |
|
|
2024
Q4 | $1.49M | Buy |
22,615
+4,609
| +26% | +$303K | 0.01% | 659 |
|
|
2024
Q3 | $1.27M | Buy |
18,006
+1,185
| +7% | +$83.3K | 0.01% | 686 |
|
|
2024
Q2 | $1.39M | Buy |
16,821
+514
| +3% | +$42.3K | 0.01% | 639 |
|
|
2024
Q1 | $1.42M | Sell |
16,307
-3,491
| -18% | -$305K | 0.01% | 639 |
|
|
2023
Q4 | $1.91M | Buy |
19,798
+379
| +2% | +$36.5K | 0.01% | 532 |
|
|
2023
Q3 | $1.72M | Sell |
19,419
-329
| -2% | -$29.1K | 0.01% | 537 |
|
|
2023
Q2 | $1.71M | Buy |
19,748
+186
| +1% | +$16.1K | 0.01% | 537 |
|
|
2023
Q1 | $1.9M | Sell |
19,562
-368
| -2% | -$35.8K | 0.01% | 508 |
|
|
2022
Q4 | $2.06M | Sell |
19,930
-7,246
| -27% | -$750K | 0.02% | 471 |
|
|
2022
Q3 | $2.3M | Buy |
27,176
+7,984
| +42% | +$677K | 0.02% | 417 |
|
|
2022
Q2 | $1.59M | Buy |
19,192
+96
| +0.5% | +$7.96K | 0.01% | 514 |
|
|
2022
Q1 | $1.47M | Buy |
19,096
+3,189
| +20% | +$246K | 0.01% | 589 |
|
|
2021
Q4 | $1.41M | Sell |
15,907
-570
| -3% | -$50.4K | 0.01% | 604 |
|
|
2021
Q3 | $1.27M | Buy |
16,477
+1,845
| +13% | +$143K | 0.01% | 612 |
|
|
2021
Q2 | $1.22M | Sell |
14,632
-630
| -4% | -$52.6K | 0.01% | 580 |
|
|
2021
Q1 | $1.15M | Sell |
15,262
-1,427
| -9% | -$108K | 0.01% | 571 |
|
|
2020
Q4 | $1.46M | Buy |
16,689
+5,341
| +47% | +$469K | 0.01% | 482 |
|
|
2020
Q3 | $863K | Buy |
11,348
+2,417
| +27% | +$184K | 0.01% | 547 |
|
|
2020
Q2 | $755K | Sell |
8,931
-10,030
| -53% | -$848K | 0.02% | 441 |
|
|
2020
Q1 | $1.6M | Buy |
18,961
+3,770
| +25% | +$319K | 0.02% | 365 |
|
|
2019
Q4 | $1.28M | Sell |
15,191
-9,229
| -38% | -$779K | 0.01% | 453 |
|
|
2019
Q3 | $1.65M | Buy |
24,420
+8,003
| +49% | +$539K | 0.01% | 383 |
|
|
2019
Q2 | $1.41M | Sell |
16,417
-1,233
| -7% | -$106K | 0.01% | 418 |
|
|
2019
Q1 | $1.57M | Buy |
17,650
+933
| +6% | +$82.8K | 0.01% | 386 |
|
|
2018
Q4 | $1.42M | Buy |
16,717
+9,650
| +137% | +$821K | 0.01% | 373 |
|
|
2018
Q3 | $685K | Buy |
7,067
+300
| +4% | +$29.1K | 0.01% | 567 |
|
|
2018
Q2 | $637K | Hold |
6,767
| – | – | 0.01% | 587 |
|
|
2018
Q1 | $549K | Buy |
6,767
+1,567
| +30% | +$127K | ﹤0.01% | 596 |
|
|
2017
Q4 | $464K | Hold |
5,200
| – | – | ﹤0.01% | 630 |
|
|
2017
Q3 | $484K | Buy |
5,200
+250
| +5% | +$23.3K | ﹤0.01% | 584 |
|
|
2017
Q2 | $450K | Buy |
4,950
+50
| +1% | +$4.55K | ﹤0.01% | 583 |
|
|
2017
Q1 | $430K | Buy |
4,900
+600
| +14% | +$52.7K | ﹤0.01% | 597 |
|
|
2016
Q4 | $356K | Buy |
4,300
+500
| +13% | +$41.4K | ﹤0.01% | 617 |
|
|
2016
Q3 | $352K | Hold |
3,800
| – | – | ﹤0.01% | 565 |
|
|
2016
Q2 | $296K | Hold |
3,800
| – | – | ﹤0.01% | 583 |
|
|
2016
Q1 | $313K | Buy |
3,800
+200
| +6% | +$16.5K | ﹤0.01% | 569 |
|
|
2015
Q4 | $377K | Sell |
3,600
-8,000
| -69% | -$838K | ﹤0.01% | 539 |
|
|
2015
Q3 | $1.22M | Sell |
11,600
-1,300
| -10% | -$137K | 0.01% | 333 |
|
|
2015
Q2 | $1.76M | Buy |
12,900
+9,100
| +239% | +$1.24M | 0.01% | 302 |
|
|
2015
Q1 | $474K | Hold |
3,800
| – | – | ﹤0.01% | 466 |
|
|
2014
Q4 | $344K | Sell |
3,800
-14,233
| -79% | -$1.29M | ﹤0.01% | 500 |
|
|
2014
Q3 | $1.3M | Sell |
18,033
-20,608
| -53% | -$1.49M | 0.01% | 263 |
|
|
2014
Q2 | $2.4M | Sell |
38,641
-5,880
| -13% | -$366K | 0.02% | 212 |
|
|
2014
Q1 | $3.04M | Buy |
44,521
+40,121
| +912% | +$2.74M | 0.02% | 197 |
|
|
2013
Q4 | $310K | Hold |
4,400
| – | – | ﹤0.01% | 524 |
|
|
2013
Q3 | $318K | Buy |
4,400
+600
| +16% | +$43.4K | ﹤0.01% | 509 |
|
|
2013
Q2 | $212K | Buy |
+3,800
| New | +$212K | ﹤0.01% | 631 |
|